BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26683656)

  • 1. Aberrant Protocadherin17 (PCDH17) Methylation in Serum is a Potential Predictor for Recurrence of Early-Stage Prostate Cancer Patients After Radical Prostatectomy.
    Lin YL; Deng QK; Wang YH; Fu XL; Ma JG; Li WP
    Med Sci Monit; 2015 Dec; 21():3955-690. PubMed ID: 26683656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant methylation of protocadherin 17 and its clinical significance in patients with prostate cancer after radical prostatectomy.
    Lin YL; Xie PG; Wang L; Ma JG
    Med Sci Monit; 2014 Aug; 20():1376-82. PubMed ID: 25091018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of Protocadherin10 (PCDH10) Methylation in Serum of Prostate Cancer Patients.
    Deng QK; Lei YG; Lin YL; Ma JG; Li WP
    Med Sci Monit; 2016 Feb; 22():516-21. PubMed ID: 26881880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant methylation of PCDH10 predicts worse biochemical recurrence-free survival in patients with prostate cancer after radical prostatectomy.
    Wang L; Xie PG; Lin YL; Ma JG; Li WP
    Med Sci Monit; 2014 Aug; 20():1363-8. PubMed ID: 25086586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant Promoter Methylation of Protocadherin8 (PCDH8) in Serum is a Potential Prognostic Marker for Low Gleason Score Prostate Cancer.
    Lin YL; Li YL; Ma JG
    Med Sci Monit; 2017 Oct; 23():4895-4900. PubMed ID: 29026066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical value of cholinesterase in the prediction of biochemical recurrence after radical prostatectomy.
    D'Andrea D; Soria F; Abufaraj M; Gust K; Foerster B; Vartolomei MD; Kimura S; Mari A; Briganti A; Remzi M; Seitz CK; Mathieu R; Karakiewicz PI; Shariat SF
    Urol Oncol; 2018 Dec; 36(12):528.e7-528.e13. PubMed ID: 30446461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Cdc20 in clinically localized prostate cancer: Relation to high Gleason score and biochemical recurrence after laparoscopic radical prostatectomy.
    Mao Y; Li K; Lu L; Si-Tu J; Lu M; Gao X
    Cancer Biomark; 2016; 16(3):351-8. PubMed ID: 26889981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant Promoter Methylation of PCDH17 (Protocadherin 17) in Serum and its Clinical Significance in Renal Cell Carcinoma.
    Lin YL; Wang YP; Li HZ; Zhang X
    Med Sci Monit; 2017 Jul; 23():3318-3323. PubMed ID: 28688232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
    Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
    Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do Ultrasensitive Prostate Specific Antigen Measurements Have a Role in Predicting Long-Term Biochemical Recurrence-Free Survival in Men after Radical Prostatectomy?
    Sokoll LJ; Zhang Z; Chan DW; Reese AC; Bivalacqua TJ; Partin AW; Walsh PC
    J Urol; 2016 Feb; 195(2):330-6. PubMed ID: 26307160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for biochemical recurrence after robotic assisted radical prostatectomy: a single surgeon experience.
    Tanimoto R; Fashola Y; Scotland KB; Calvaresi AE; Gomella LG; Trabulsi EJ; Lallas CD
    BMC Urol; 2015 Apr; 15():27. PubMed ID: 25879548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertriglyceridemia is a potential preoperative predictor for biochemical recurrence after radical prostatectomy.
    Kang M; Jeong CW; Ku JH; Kwak C; Kim HH
    PLoS One; 2015; 10(3):e0122438. PubMed ID: 25803284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative combined nested reverse transcriptase polymerase chain reaction for prostate-specific antigen and prostate-specific membrane antigen does not correlate with pathologic stage or biochemical failure in patients with localized prostate cancer undergoing radical prostatectomy.
    Thomas J; Gupta M; Grasso Y; Reddy CA; Heston WD; Zippe C; Dreicer R; Kupelian PA; Brainard J; Levin HS; Klein EA
    J Clin Oncol; 2002 Aug; 20(15):3213-8. PubMed ID: 12149293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative predictive factors and further risk stratification of biochemical recurrence in clinically localized high-risk prostate cancer.
    Hamada R; Nakashima J; Ohori M; Ohno Y; Komori O; Yoshioka K; Tachibana M
    Int J Clin Oncol; 2016 Jun; 21(3):595-600. PubMed ID: 26585896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative prostate health index is an independent predictor of early biochemical recurrence after radical prostatectomy: Results from a prospective single-center study.
    Lughezzani G; Lazzeri M; Buffi NM; Abrate A; Mistretta FA; Hurle R; Pasini L; Castaldo L; Zandegiacomo De Zorzi S; Peschechera R; Fiorini G; Taverna G; Casale P; Guazzoni G
    Urol Oncol; 2015 Aug; 33(8):337.e7-14. PubMed ID: 26055430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns and predictors of early biochemical recurrence after radical prostatectomy and adjuvant radiation therapy in men with pT3N0 prostate cancer: implications for multimodal therapies.
    Briganti A; Joniau S; Gandaglia G; Cozzarini C; Sun M; Tombal B; Haustermans K; Hinkelbein W; Shariat SF; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):960-7. PubMed ID: 24351411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical prostatectomy and positive surgical margins: relationship with prostate cancer outcome.
    De La Roca RL; Da Cunha IW; Bezerra SM; Da Fonseca FP
    Int Braz J Urol; 2014; 40(3):306-15. PubMed ID: 25010296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of serum response factor expression in prostate cancer biochemical recurrence.
    Prencipe M; Fabre A; Murphy TB; Vargyas E; O'Neill A; Bjartell A; Tasken KA; Grytli HH; Svindland A; Berge V; Eri LM; Gallagher W; Watson RW
    Prostate; 2018 Jul; 78(10):724-730. PubMed ID: 29608018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.
    Freedland SJ; Wieder JA; Jack GS; Dorey F; deKernion JB; Aronson WJ
    J Urol; 2002 Jul; 168(1):110-5. PubMed ID: 12050502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percentage of high-grade tumour volume does not meaningfully improve prediction of early biochemical recurrence after radical prostatectomy compared with Gleason score.
    Hansen J; Bianchi M; Sun M; Rink M; Castiglione F; Abdollah F; Steuber T; Ahyai SA; Steurer S; Göbel C; Freschi M; Montorsi F; Shariat SF; Fisch M; Graefen M; Karakiewicz PI; Briganti A; Chun FK
    BJU Int; 2014 Mar; 113(3):399-407. PubMed ID: 24053339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.